Make your money go further for just 25p per day

PREMIUM

Dividend dogs vs diamonds: Part 2 – paying the price of quality

23/05/2019 · AstraZeneca (AZN)  · Compass (CPG)  · Diageo (DGE)  · GSK (GSK)  · Next (NXT)  · Persimmon (PSN)  · Relx (RELX)  · Unilever (ULVR) 

Dividends FTSE 100 Investment Ideas UK

Relx logo on board in headquarters

With seven FTSE 100 dividend stalwarts currently yielding over 8%, investors are starting to ditch companies which might follow Vodafone’s lead and cut their pay-outs. But the stocks whose dividends you can rely on come with an added valuation risk which investors might want to avoid.


In part one of our mini-series on dividends, we looked at the FTSE 100 companies which are likely to follow Vodafone’s lead and cut their dividends in 2019. We suggested that a yield of over 8% is a major red flag for investors considering the future of their income.

But if you’re going to dump the dividend dogs out of fear of a cut, where should you re-invest your money if you want to continue to…

Continue reading our content…

Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
  • Unlimited access to our market-beating portfolios
  • In-depth coverage of many of the world’s great companies
  • Unique insights from our top research team
Register FREE for access to limited content.
  • Company and markets insights
  • Sponsored content
  • Podcasts

Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on AstraZeneca

Overhyped perhaps - but don’t ignore AI!

03/07/2024 · Company Insights

Is AI overhyped? Of course it is, but there are still plenty of opportunities for investors…


AstraZeneca vs GlaxoSmithKline: a clear coronavirus winner?

31/07/2020 · Company Insights

The pharmaceutical industry has enjoyed a strong 2020. These are companies which – in the eyes…


More on Compass

Dividend dogs vs diamonds: Part 2 – paying the price of quality

23/05/2019 · Company Insights

With seven FTSE 100 dividend stalwarts currently yielding over 8%, investors are starting to ditch companies…


More on Diageo

Staggering growth | Decent results | On the up

02/06/2025 · Portfolio

Our technology giant delivered another record quarter of sales, despite restrictions in a key market. Elsewhere,…


Ultimate Stocks Portfolio: something for everyone

11/02/2025 · Portfolio

Our portfolio of high-quality companies offers something for everyone, as you will appreciate in another of…


More on GSK

Income Boosters: strong performance in 2025

09/01/2026 · Portfolio

After a good year for the UK market, our high yield portfolio offers a 7% income…


Income Boosters: Q3 2025 portfolio review

10/10/2025 · Portfolio

Our high yield portfolio delivered twice as much income as the high-flying FTSE 100 in 3rd…


More on Next

Ultimate Stocks Portfolio: winning ways

31/10/2025 · Portfolio

Reporting season has brought the usual staggering numbers from our tech giants, which continue to redeploy…


Speed goals | New parks | Tech tremors

09/05/2025 · Portfolio

Results covered in our update here from companies in our Ultimate Stocks Portfolio are generally positive, with…


More on Persimmon

Do our Income Boosters need a housebuilder?

29/03/2021 · Portfolio

With UK housebuilders offering yields up to 8%, should we add one to our Income Boosters dividend…


Income Boosters: Does our dividend portfolio need a housebuilder?

18/09/2020 · Portfolio

Housebuilders have become income favourites in recent years, but our income portfolio doesn't have any exposure…


More on Relx

Ultimate Stocks: ignoring the noise

12/02/2026 · Portfolio

News covered here from our portfolio of high-quality companies includes our assessment of strong results from…


When knocking the lights out isn’t enough

28/02/2025 · Portfolio

As results season draws to a close several of our high quality companies have delivered fabulous…


More on Unilever

Ultimate Stocks: ignoring the noise

12/02/2026 · Portfolio

News covered here from our portfolio of high-quality companies includes our assessment of strong results from…


When knocking the lights out isn’t enough

28/02/2025 · Portfolio

As results season draws to a close several of our high quality companies have delivered fabulous…


More Company Insights

AI encouragement | Big contract win | On the mend

Unexpected upgrade | Amazing growth | Genesis

Bonkers Bargains: how does it do it?

03/02/2026 · Alumasc

More on AstraZeneca

Overhyped perhaps - but don’t ignore AI!

AstraZeneca vs GlaxoSmithKline: a clear coronavirus winner?

Coronavirus impact: 29 April - surging profits and depression era declines

Global investment round-up: this week’s top stories

More on Compass

Dividend dogs vs diamonds: Part 2 – paying the price of quality

More on Diageo

Staggering growth | Decent results | On the up

Ultimate Stocks Portfolio: something for everyone

Episode 29 of the Investor’s Champion Podcast

Game delights | Consumer facing weakness | Tech delivers

More on GSK

Income Boosters: strong performance in 2025

Income Boosters: Q3 2025 portfolio review

Income Boosters: cash-backed dividends with growth potential

Income Boosters: strong gains for our high yield stocks

More on Next

Ultimate Stocks Portfolio: winning ways

Speed goals | New parks | Tech tremors

Episode 34 of the Investor’s Champion Podcast

Episode 10 of the Investor’s Champion Podcast

More on Persimmon

Do our Income Boosters need a housebuilder?

Income Boosters: Does our dividend portfolio need a housebuilder?

Coronavirus impact: 29 April - surging profits and depression era declines

European expansion boosts IHT qualifying Michelmersh

More on Relx

Ultimate Stocks: ignoring the noise

When knocking the lights out isn’t enough

Ultimate Stocks company updates: luxurious returns

Ultimate Stocks: Recovery gathering momentum in 2023

More on Unilever

Ultimate Stocks: ignoring the noise

When knocking the lights out isn’t enough

Episode 28 of the Investor’s Champion Podcast

Income Boosters: making progress in mixed markets

More Company Insights

AI encouragement | Big contract win | On the mend
Unexpected upgrade | Amazing growth | Genesis
Bonkers Bargains: how does it do it?

Sign-up to our free email updates

SIGN UP